Mateon Therapeutics Inc Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MATN and buy or sell other stocks, ETFs, and their options commission-free!

About MATN

Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. 

CEO
Vuong Trieu, PhD
CEOVuong Trieu, PhD
Employees
40
Employees40
Headquarters
Agoura Hills, California
HeadquartersAgoura Hills, California
Founded
1988
Founded1988
Employees
40
Employees40

MATN Key Statistics

Market cap
105.90M
Market cap105.90M
Price-Earnings ratio
-5.10
Price-Earnings ratio-5.10
Dividend yield
—
Dividend yield—
Average volume
65.16K
Average volume65.16K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.07
52 Week high$0.07
52 Week low
$0.017
52 Week low$0.017
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.